| Literature DB >> 25773640 |
Andrea R Halpern1, Hannah L Golden, Nadia Magdalinou, Pirada Witoonpanich, Jason D Warren.
Abstract
Studies of musical abilities in dementia have for the most part been rather general assessments of abilities, for instance, assessing retention of music learned premorbidly. Here, we studied patients with dementias with contrasting cognitive profiles to explore specific aspects of music cognition under challenge. Patients suffered from Alzheimer's disease (AD), in which a primary impairment is in forming new declarative memories, or Lewy body disease (PD/LBD), a type of parkinsonism in which executive impairments are prominent. In the AD patients, we examined musical imagery. Behavioral and neural evidence confirms involvement of perceptual networks in imagery, and these are relatively spared in early stages of the illness. Thus, we expected patients to have relatively intact imagery in a mental pitch comparison task. For the LBD patients, we tested whether executive dysfunction would extend to music. We probed inhibitory skills by asking for a speeded pitch or timbre judgment when the irrelevant dimension was held constant or also changed. Preliminary results show that AD patients score similarly to controls in the imagery tasks, but PD/LBD patients are impaired relative to controls in suppressing some irrelevant musical dimensions, particularly when the required judgment varies from trial to trial.Entities:
Keywords: Alzheimer's disease; Parkinson's disease; auditory imagery; executive function
Mesh:
Year: 2015 PMID: 25773640 PMCID: PMC4401999 DOI: 10.1111/nyas.12616
Source DB: PubMed Journal: Ann N Y Acad Sci ISSN: 0077-8923 Impact factor: 5.691
General demographic, clinical, and neuropsychological data for patient groups
| Characteristics | AD | PDD/DLB |
|---|---|---|
| General demographic | ||
| No. (male:female) | 5:3 | 7:3 |
| Age (years) | 72.0 (7.3) | 72.4 (7.0) |
| Musical training (years) | 5.8 (3.6) | 3.7 (4.3) |
| Neuropsychological assessment | ||
| WASI verbal IQ | 108.2 (10.4) | 104.6 (9.9) |
| WASI performance IQ | 99.6 (19.3) | 85.6 (11.2) |
| NART predicted IQ | 118.6 (7.1) | 109.1 (11.4) |
| Episodic memory | ||
| RMT faces | −1.3 (1.0) | −0.5 (1.7) |
| RMT words | −2.5 (1.2) | −1.3 (1.4) |
| Executive skills | ||
| WMS-R digit span forward | 0.3 (0.9) | 0.1 (1.0) |
| WMS-R digit span reverse | 0.1 (0.7) | −0.4 (1.0) |
| D-KEFs Stroop color | −1.4 (1.7) | −1.5 (1.3) |
| D-KEFs Stroop word | −0.9 (2.0) | −0.9 (1.7) |
| D-KEFs Stroop interference | −1.1 (1.5) | −1.5 (1.3) |
| Verbal skills | ||
| GNT | 0.5 (1.3) | 0.7 (1.4) |
| Posterior cortical skills | ||
| GDA | −0.4 (1.1) | −1.3 (0.7) |
| VOSP object decision | −1.4 (1.1) | −1.7 (0.6) |
One of the PDD/DLB patients could not complete this subtest.
Note: Mean (standard deviation) shown for demographic characteristics and Z-scores are shown for neuropsychological tests unless otherwise stated.
Abbreviations: AD, patients with a diagnosis of Alzheimer's disease; D-KEFS, Delis Kaplan Executive System; DLB, patients with a diagnosis of Dementia with Lewy bodies; GDA, Graded Difficulty Arithmetic; GNT, Graded Naming Test; NART, National Adult Reading Test; PDD, patients with a diagnosis of Parkinson's disease dementia; RMT, Recognition Memory Test; VOSP, Visual Object and Spatial Perception Battery; WASI, Wechsler Abbreviated Scale of Intelligence; WMS-R, Wechsler Memory Scale Revised.
Figure 1Schematic of four conditions presented in Block 3, reflecting the possible change of two elements: (1) type of judgment and (2) whether the irrelevant dimension was fixed or changed. This resulted in four subtypes of trials: pitch judgment with instrument fixed within pairs; pitch judgment with instrument change within pairs; instrument judgment with pitch fixed within pairs; and instrument judgment with pitch change within pairs.
Figure 2Accuracy and reaction times in PDD/DLB patients and controls. *P < 0.05.
Figure 3Accuracy in deciding if the second note is higher or lower than the first in perceived and imagined familiar songs, in Alzheimer's disease (AD) patients and controls. *P < 0.05.